{
    "nctId": "NCT01118871",
    "title": "A Randomised, Open Label, Prospective Study to Assess Two Different Therapeutic Strategies Following First Treatment Failure in HIV-1 Infected Subjects",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "HIV-1 infected males or females"
                    },
                    {
                        "type": "variable",
                        "value": "over 18 years of age"
                    },
                    {
                        "type": "variable",
                        "value": "signed informed consent"
                    },
                    {
                        "type": "and",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "currently receiving a stable antiretroviral regimen comprising of two or more licensed NRTIs"
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "one licensed NNRTI"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "boosted protease inhibitor"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "not",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "previous protease inhibitor resistance documented on HIV-1 genotypic resistance testing"
                            }
                        ]
                    },
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "toxicity, intolerance or virological failure if receiving an NNRTI containing regimen at screening"
                                    }
                                ]
                            },
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "toxicity or intolerance if receiving a boosted-protease inhibitor regimen at screening"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "plasma HIV RNA < 400 copies/mL at screening"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "willing to modify antiretroviral therapy, in accordance with the randomisation assignment"
                    },
                    {
                        "type": "not",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "previous exposure to etravirine"
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "subjects in good health upon medical history, physical exam, and laboratory testing in the opinion of the investigator"
                    },
                    {
                        "type": "not",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "serologic evidence of active HBV infection evidenced by negative hepatitis B surface antigen"
                            }
                        ]
                    },
                    {
                        "type": "and",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "female subjects who are heterosexually active and of childbearing potential must practice contraception from screening through completion of the study"
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "barrier contraceptives (condom, diaphragm with spermicide)"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "IUD or Depo PLUS a barrier contraceptive"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "female subjects of childbearing potential must have a negative pregnancy test"
                    },
                    {
                        "type": "variable",
                        "value": "must have minimum age of 18 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "current alcohol abuse or drug dependence"
                            },
                            {
                                "type": "variable",
                                "value": "pregnancy"
                            },
                            {
                                "type": "variable",
                                "value": "active opportunistic infection or significant co-morbidities"
                            },
                            {
                                "type": "variable",
                                "value": "current prohibited concomitant medication"
                            },
                            {
                                "type": "variable",
                                "value": "a likelihood of diminished response to any of the study treatment arms, in the opinion of the investigator, based on HIV genotypic resistance testing"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('HIV-1 infected males or females'), Symbol('currently receiving a stable antiretroviral regimen comprising of two or more licensed NRTIs'), Symbol('female subjects of childbearing potential must have a negative pregnancy test'), Symbol('female subjects who are heterosexually active and of childbearing potential must practice contraception from screening through completion of the study'), Symbol('must have minimum age of 18 Years'), Symbol('over 18 years of age'), Symbol('signed informed consent'), Symbol('subjects in good health upon medical history, physical exam, and laboratory testing in the opinion of the investigator'), Symbol('willing to modify antiretroviral therapy, in accordance with the randomisation assignment'), Not(Symbol('previous exposure to etravirine')), Not(Symbol('previous protease inhibitor resistance documented on HIV-1 genotypic resistance testing')), Not(Symbol('serologic evidence of active HBV infection evidenced by negative hepatitis B surface antigen')), Or(Symbol('IUD or Depo PLUS a barrier contraceptive'), Symbol('barrier contraceptives (condom, diaphragm with spermicide)')), Or(Symbol('boosted protease inhibitor'), Symbol('one licensed NNRTI')), Or(Symbol('toxicity, intolerance or virological failure if receiving an NNRTI containing regimen at screening'), And(Symbol('plasma HIV RNA < 400 copies/mL at screening'), Symbol('toxicity or intolerance if receiving a boosted-protease inhibitor regimen at screening'))), Not(Or(Symbol('a likelihood of diminished response to any of the study treatment arms, in the opinion of the investigator, based on HIV genotypic resistance testing'), Symbol('active opportunistic infection or significant co-morbidities'), Symbol('current alcohol abuse or drug dependence'), Symbol('current prohibited concomitant medication'), Symbol('pregnancy'))))"
}